Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase Ib Trial to Determine the Optimal Selenium Status to Prevent Colorectal Adenoma Recurrence: OSCAR

NCT04952129 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.

NCT NCT04952129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04952129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase Ib Trial to Determine the Optimal Selenium Status to Prevent Colorectal Adenoma Recurrence: OSCAR
Lead sponsor
University of Auckland, New Zealand
Phase
Phase 1
Overall status
Completed
Start date
May 6, 2022
Completion date
December 11, 2023
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma